This raises an interesting question regarding ICI and the role of CTLA-4 on Tregs: how can ICI induce tumor regression and anti-tumor immune responses, if both Tregs and Teff are expanded and activated during treatment? This evidence concerns the gene CTLA4 and neoplasm.